Abstract
Acetylcholinesterase (AChE) is an attractive target of drugs for Alzheimer’s disease (AD). A series of novel synthesized flavonoid derivatives have been reported as potent AChE inhibitors, but the lack of structure-AChE inhibitory activity relationships hampers the design of specific and selective flavonoid derivatives. In this study, 3D-quantitative structure activity relationship (3D-QSAR) models of 90 flavonoid derivatives as AChE inhibitors were established by using CoMFA and CoMSIA techniques. The results showed that both CoMFA model (q2= 0.651, r2= 0.939, F value = 173.5 and SEE=0.218 ) and CoMSIA model (q2= 0.680, r2= 0.947, F value = 151.8 and SEE=0.226) demonstrated statistically significant results and good predictive ability. Furthermore, docking studies were used for better understanding of the binding modes between flavonoid inhibitors and AChE. In conclusion, the essential information obtained from this study could provide valuable insight for further modification of highly potent AChE inhibitors.
Keywords: AChE inhibitors, flavonoid derivatives, 3D-QSAR, CoMFA, CoMSIA, molecular docking.
Letters in Drug Design & Discovery
Title:3D-QSAR and Molecular Docking Studies of Flavonoid Derivatives as Potent Acetylcholinesterase Inhibitors
Volume: 12 Issue: 10
Author(s): An Zhou, Zeyu Wu, Ailing Hui, Bin Wang, Xianchun Duan, Haixiang Wang and Jian Pan
Affiliation:
Keywords: AChE inhibitors, flavonoid derivatives, 3D-QSAR, CoMFA, CoMSIA, molecular docking.
Abstract: Acetylcholinesterase (AChE) is an attractive target of drugs for Alzheimer’s disease (AD). A series of novel synthesized flavonoid derivatives have been reported as potent AChE inhibitors, but the lack of structure-AChE inhibitory activity relationships hampers the design of specific and selective flavonoid derivatives. In this study, 3D-quantitative structure activity relationship (3D-QSAR) models of 90 flavonoid derivatives as AChE inhibitors were established by using CoMFA and CoMSIA techniques. The results showed that both CoMFA model (q2= 0.651, r2= 0.939, F value = 173.5 and SEE=0.218 ) and CoMSIA model (q2= 0.680, r2= 0.947, F value = 151.8 and SEE=0.226) demonstrated statistically significant results and good predictive ability. Furthermore, docking studies were used for better understanding of the binding modes between flavonoid inhibitors and AChE. In conclusion, the essential information obtained from this study could provide valuable insight for further modification of highly potent AChE inhibitors.
Export Options
About this article
Cite this article as:
Zhou An, Wu Zeyu, Hui Ailing, Wang Bin, Duan Xianchun, Wang Haixiang and Pan Jian, 3D-QSAR and Molecular Docking Studies of Flavonoid Derivatives as Potent Acetylcholinesterase Inhibitors, Letters in Drug Design & Discovery 2015; 12 (10) . https://dx.doi.org/10.2174/1570180812666150514233543
DOI https://dx.doi.org/10.2174/1570180812666150514233543 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Mechanisms for Antiplatelet Action of Statins
Current Drug Targets - Cardiovascular & Hematological Disorders Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
Current Neuropharmacology Editorial (Thematic Issue: Mechanisms of Atherogenesis and Development of Anti-Atherosclerotic Therapy)
Current Pharmaceutical Design Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
Current Pharmaceutical Design Chronic Alcohol Abuse and HIV Disease Progression: Studies with the Non-Human Primate Model
Current HIV Research Regression to the Mean: Implications for Clinical Trials of Psychotropic Agents in Dementia
Current Alzheimer Research Allosteric Enhancers for A1 Adenosine Receptor
Mini-Reviews in Medicinal Chemistry Pharmacology of the Intracellular Pathways Activated by Amyloid Beta Protein
Mini-Reviews in Medicinal Chemistry Reviewing the Role of Donepezil in the Treatment of Alzheimer’s Disease
Current Alzheimer Research Physical Exercise for the Treatment of Neuropsychiatric Disturbances in Alzheimer’s Dementia: Possible Mechanisms, Current Evidence and Future Directions
Current Alzheimer Research Therapeutic Effects of Rivastigmine and Alfa-Lipoic Acid Combination in the Charles Bonnet Syndrome: Electroencephalography Correlates
Current Clinical Pharmacology Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review
Combinatorial Chemistry & High Throughput Screening Fluorescent Imaging of Amyloid-β Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for In Vivo Imaging
Current Medicinal Chemistry Patient Variables Associated with the Assignment of a Formal Dementia Diagnosis to Positively Screened Primary Care Patients
Current Alzheimer Research An Overview of Phytochemical and Pharmacological Profile of <i>Morus alba</i> Linn
Current Bioactive Compounds Hsp20 Protects Neuroblastoma Cells from Ischemia/Reperfusion Injury by Inhibition of Apoptosis via a Mechanism that Involves the Mitochondrial Pathways
Current Neurovascular Research Phosphodiesterase: An Interface Connecting Cognitive Deficits to Neuropsychiatric and Neurodegenerative Diseases
Current Pharmaceutical Design Differential Susceptibility of Naive and Differentiated PC-12 Cells to Methylglyoxal-Induced Apoptosis: Influence of Cellular Redox
Current Neurovascular Research Myelin Sheaths and Autoimmune Response Induced by Myelin Proteins and Alphaviruses. I. Physicochemical Background
Current Medicinal Chemistry